A) MONITORING OF PATIENT
1) Obtain a radiograph of the chest and abdomen to determine the location of the battery.
2) Routine laboratory evaluation is not indicated.
3) If the patient has clinical evidence of bleeding, CBC, type and cross, and coagulation panel may be indicated.
B) DILUTION
1) NEUTRALIZATION
a) An in vivo study in cats demonstrated no benefit from administration of various diluents, including vinegar, orange juice, and Mylanta II (R), on severity of esophageal injury 2 hours after placement of a manganese dioxide disc battery (Rivera & Maves, 1987).
C) RADIOGRAPHIC IMAGING PROCEDURE
1) X-RAY LOCALIZATION is recommended in all cases of suspected button battery ingestion to confirm the diagnosis, exclude an esophageal location, and serve as baseline so the progress of the battery through the GI tract can be followed by subsequent radiographs. An approximation of battery size should be determined from this initial film (or from inspection of a replacement battery).
2) X-rays should be taken so as to include the area from the top of the nose and ear canals down to the rectal areas, and should include both a PA and lateral film. An approximation of battery size should also be determined from this initial film. Estimate whether battery is the size of a quarter (24 mm) or the size of a dime (18 mm), pencil eraser (6 to 7 mm)(Litovitz et al, 2010).
3) Most batteries which become lodged in the esophagus are 20 mm or bigger in diameter.
4) CASE SERIES: Gossweiler et al (1999) reported a series of 1095 pediatric button battery ingestions. Of these, 756 (69%) required no emergency department admission and 339 (31%) required medical evaluation. 220 (93%) of the evaluated children remained symptom free, with batteries excreted in feces and no late GI complications developing. 16 children (7%) experienced mild symptoms, with only one child developing a severe outcome (battery radiographically localized in esophagus, developed esophageal perforation, mediastinitis and delayed stricture formation). The authors conclude that radiographic evaluation is indicated only in symptomatic patients (Gossweiler et al, 1999).
5) CASE SERIES: Litovitz et al (2010) studied a series of 8648 children with reported button battery ingestions to the National Battery Ingestion Hotline, with ingestions confirmed in 81.9% cases. 6349 children (77.8%) remained asymptomatic; 508 children (6.22%) experienced minor effects; 129 children (1.58%) experienced moderate effects, 41 children (0.5%) experience major effects, and 2 children (0.02%) died. The 20 mm lithium cell was implicated in majority of severe injuries, especially in children younger than 4 years of age. Injuries extended after removal, with delayed esophageal perforations, tracheoesophageal fistulas, and hemorrhage. The authors advocate radiographic confirmation for all patients who ingest button batteries, noting the high rate of missed diagnosis of serious ingestions (Litovitz et al, 2010).
D) ENDOSCOPIC PROCEDURE
1) Endoscopic or surgical removal is indicated in the symptomatic patient or when there is evidence of esophageal impaction or a corroded battery. Endoscopic or surgical removal may be considered in cases where the battery stops progressing through the GI tract or if the battery is larger than 20 mm in diameter.
2) BATTERY LOCATED IN THE ESOPHAGUS require emergent endoscopic removal. Although the success rate of button battery retrieval by endoscopy from the more distal parts of the gastrointestinal tract has been extremely low (about one third of attempts are successful), battery retrieval from the esophagus by endoscopy has proved uniformly successful.
3) Endoscopic retrieval may be more successful with the use of a fiberoptic endoscope equipped with a basket rather than pinchers. Additionally, the attachment of a small magnet to the tip of the endoscope may aid in battery retrieval. Where endoscopy fails (and in the presence of peritoneal signs and symptoms), laparotomy may be required.
4) One study (Volle et al, 1989) recommends immediate removal of batteries lodged in the esophagus less than 24 to 30 hours with the FE-EX(R) OGTM (oral gastric tube magnet) procedure under fluoroscopic control. Esophageal battery lodgement greater than 50 hours should be removed via endoscopic techniques. McDermott et al (1995) reported successful battery removal in 32 children, without anesthesia, by use of an orogastric magnet under fluoroscopy (McDermott et al, 1995).
5) Some authors recommend battery retrieval from the esophagus utilizing the Foley Catheter technique (Rumack & Rumack, 1983), but this procedure does not allow direct assessment of the severity of esophageal injury, and should be avoided if the battery has been lodged for more than 24 hours or the patient is symptomatic.
a) Furthermore, this is a blind technique and may therefore pose a greater risk of esophageal perforation (in the setting of chemical and electrical esophageal burns) than retrieval under direct endoscopic visualization.
b) Disc batteries are often found to be adherent to the esophagus, requiring greater care in removal than allowed by the Foley technique (Maves et al, 1986).
E) FOREIGN BODY IN STOMACH
1) IF THE BATTERY HAS PASSED BEYOND THE ESOPHAGUS, the patient may be sent home and instructed to watch for vomiting, tarry or bloody stools, fever, abdominal pain, or decreased appetite.
2) If the patient remains asymptomatic, hospitalization is NOT indicated, and the patient should NOT be placed NPO or restricted to fluids, as these maneuvers may delay gastric transit. A normal activity level and diet should be permitted.
3) MAGNETS: Co-ingested batteries and magnets require prompt removal, endoscopically if possible, surgically if not (Litovitz et al, 2010).
4) REPEAT X-RAY
a) In the absence of symptoms a REPEAT X-RAY may be performed 4 to 7 days after the ingestion if battery passage in the stool has not been documented. If this roentgenogram demonstrates a persistent gastric position of the battery, several doses of metoclopramide are advised, based on the theoretical advantages of rapid gastric transport.
b) X-ray evidence of a battery becoming "hung-up" at a certain location in the gastrointestinal tract beyond the esophagus does NOT mandate endoscopic or surgical intervention in an asymptomatic patient. If battery transit is arrested, endoscopic or surgical intervention are indicated in the presence of associated symptoms.
c) More frequent (daily) x-ray localization of the battery is indicated for the larger 23 millimeters diameter cells as these often fail to pass spontaneously beyond the pylorus.
5) METOCLOPRAMIDE/CIMETIDINE
a) Metoclopramide administration may speed gastric transit of these cells, and cimetidine administration may minimize acid-induced corrosion. These therapeutic adjuncts, however, are currently only recommended for the larger size button cells because of the frequent association of delayed gastric transit with these cells.
b) The clinician should note that their recommended use is based on entirely theoretical considerations; no controlled clinical trials or animal studies document their efficacy.
c) Cimetidine, metoclopramide, and magnesium citrate were not shown to protect against button-battery injury in dogs (Litovitz et al, 1984).
F) SURGICAL PROCEDURE
1) LAPAROTOMY INDICATIONS
a) Failure of endoscopic removal in a symptomatic patient, mucosal damage, or a badly corroding battery (usually the battery is pushed into the stomach and a gastrotomy is performed) (Thompson et al, 1990)
b) Signs of peritonitis (Kuhns & Dire, 1989; Anon, 1989)
c) When less invasive techniques (test of time, WBI, endoscopy) fail to retrieve the battery in an asymptomatic patient
d) Failure of WBI and the location of the battery is inaccessible to endoscopic retrieval
e) Signs of peritonitis (Kuhns & Dire, 1989; Anon, 1989)
G) MERCURY
1) The issue of concern is that mercury batteries tend to open (Litovitz & Schmitz, 1992). Although elevated mercury concentrations have been reported (Kulig et al, 1983), no clinical mercury toxicity has been described in these patients (Blatnik et al, 1977).
2) Where a button cell is noted to be split on roentgenogram, where the button cell chemical system is possibly mercuric oxide (as determined from the battery's imprint code), and especially where visible droplet-like opacities are noted on the abdominal x-ray, the split battery should be removed promptly by purging or enema and the patient's blood and urine should be evaluated for heavy metal concentrations.
3) The US Mercury-Containing and Rechargeable Battery Management Act of 1996 banned the sale of mercuric oxide button cells. Therefore, button batteries manufactured in the United States do not pose a treat of mercury toxicity.